MedPath

VARIZIG

VARIZIG

Approved
DIN Number

02442183

Drug Class

Human

Market Date

Aug 14, 2015

Company
HC

ki biopharma llc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02442183
AIG Number0115174003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB03 VARICELLA/ZOSTER IMMUNOGLOBULIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)Active
Strength: 125 UNIT / VIAL
Monograph: VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.